Skip to main content

For recipients of the Johnson & Johnson (Janssen) COVID-19 vaccine

For recipients of the Johnson & Johnson (Janssen) COVID-19 vaccine

Our records show that you recently received the Johnson & Johnson (Janssen) vaccine.  We want to update you on information about this vaccine provided by the CDC and FDA on April 13thRead the full CDC and FDA statement.

What led the CDC and FDA to recommend pausing the use of the Johnson & Johnson (Janssen) Covid-19 Vaccine?

As of April 12th, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson (Janssen) vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination.

What are the symptoms to be concerned about and what should I do if I experience these symptoms?

If you have received the Johnson & Johnson (Janssen) vaccine and develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination you should contact your health care provider, or seek medical care. Report adverse events following receipt of any COVID-19 vaccine to Vaccine Adverse Event Reporting System.

For recipients of the Johnson & Johnson (Janssen) COVID-19 vaccine

For recipients of the Johnson & Johnson (Janssen) COVID-19 vaccine

Our records show that you recently received the Johnson & Johnson (Janssen) vaccine.  We want to update you on information about this vaccine provided by the CDC and FDA on April 13thRead the full CDC and FDA statement.

What led the CDC and FDA to recommend pausing the use of the Johnson & Johnson (Janssen) Covid-19 Vaccine?

As of April 12th, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson (Janssen) vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination.

What are the symptoms to be concerned about and what should I do if I experience these symptoms?

If you have received the Johnson & Johnson (Janssen) vaccine and develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination you should contact your health care provider, or seek medical care. Report adverse events following receipt of any COVID-19 vaccine to Vaccine Adverse Event Reporting System.